A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung Cancer

NCT06643910 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

BIOLOGICAL: Single drug group A
BIOLOGICAL: Combined treatment group B

Sponsor

BioSyngen Pte Ltd

Collaborators

[object Object]